EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05

Yasuhiro Takeuchi, Shiro Tanaka, Tatsuhiko Kuroda, Hiroshi Hagino, Satoshi Mori, Satoshi Soen

Osteoporosis International · 2024

DOI: 10.1007/s00198-024-07260-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2024. Verfasst von Yasuhiro Takeuchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp. Hauptthemen laut MEDLINE: Alendronate, Bone Density Conservation Agents, Teriparatide, Osteoporotic Fractures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Public Health Research Foundation, Asahi Kasei Pharma Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlendronateBone Density Conservation AgentsTeriparatideOsteoporotic FracturesSpinal FracturesGlomerular Filtration RateRenal Insufficiency, ChronicOsteoporosis, PostmenopausalHumansFemaleAgedIncidenceAged, 80 and overDrug Administration ScheduleJapanBone DensityEast Asian People

Stichwörter der Autor:innen

AlendronateChronic kidney diseaseFracture incidenceOsteoporosisTeriparatide

Substanzen

AlendronateBone Density Conservation AgentsTeriparatide

Autor:innen und Institutionen

  • Toranomon Hospital Endocrine Center, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan. takeuchi-tky@toranomon.gr.jp.
  • Okinaka Memorial Institute for Medical Research, Minato-Ku, Tokyo, Japan. takeuchi-tky@toranomon.gr.jp.
  • Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Public Health Research Foundation, Shinjuku-Ku, Tokyo, Japan.
  • Department of Rehabilitation, Sanin Rosai Hospital, Yonago, Tottori, Japan.
  • Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Förderung

  • Public Health Research Foundation
  • Asahi Kasei Pharma Corporation

Zitieren

APA

Takeuchi, Y., Tanaka, S., Kuroda, T., Hagino, H., Mori, S., & Soen, S. (2024). Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. https://doi.org/10.1007/s00198-024-07260-9

Vancouver

Takeuchi Y, Tanaka S, Kuroda T, Hagino H, Mori S, Soen S. Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. 2024. doi:10.1007/s00198-024-07260-9

BibTeX
@article{Takeuchi2024,
  author = {Takeuchi, Yasuhiro and Tanaka, Shiro and Kuroda, Tatsuhiko and Hagino, Hiroshi and Mori, Satoshi and Soen, Satoshi},
  title = {Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05},
  journal = {Osteoporosis International},
  year = {2024},
  doi = {10.1007/s00198-024-07260-9}
}
Kostenlos starten →